t(1;7;22)(p13;q21;q13) is a novel 3-way variant of t(1;22)(p13;q13) neonatal acute megakaryoblastic leukemia: A case report.

IF 1.4 Q4 ONCOLOGY Molecular and clinical oncology Pub Date : 2023-03-01 DOI:10.3892/mco.2023.2614
Julie Messiaen, Anne Uyttebroeck, Lucienne Michaux, Peter Vandenberghe, Nancy Boeckx, Sandra A Jacobs
{"title":"t(1;7;22)(p13;q21;q13) is a novel 3-way variant of t(1;22)(p13;q13) neonatal acute megakaryoblastic leukemia: A case report.","authors":"Julie Messiaen,&nbsp;Anne Uyttebroeck,&nbsp;Lucienne Michaux,&nbsp;Peter Vandenberghe,&nbsp;Nancy Boeckx,&nbsp;Sandra A Jacobs","doi":"10.3892/mco.2023.2614","DOIUrl":null,"url":null,"abstract":"<p><p>Acute megakaryoblastic leukemia (AMKL) is a rare disease, occurring mostly in infants and young children. The chromosomal translocation t(1;22)(p13;q13), resulting in the RBM15-MKL1 fusion gene, is a recurrent and diagnostic translocation in infants with AMKL. The present case report describes a case of a newborn girl, without Down's syndrome, with congenital AMKL. At birth, the infant had hepatosplenomegaly and the peripheral blood count revealed anemia, thrombopenia and leukocytosis, with 28% blasts. Immunophenotyping demonstrated blasts positive for CD34, CD61 and CD42b. Karyotyping of these blasts (R-banding) showed a hitherto unreported chromosomal translocation, t(1;7;22)(p13;q21;q13), a 3-way variant of the t(1;22)(p13;q13) variant. Fluorescent <i>in situ</i> hybridization analysis confirmed the presence of the RBM15-MKL1 fusion gene.</p>","PeriodicalId":18737,"journal":{"name":"Molecular and clinical oncology","volume":"18 3","pages":"18"},"PeriodicalIF":1.4000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b2/fe/mco-18-03-02614.PMC9926329.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular and clinical oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3892/mco.2023.2614","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Acute megakaryoblastic leukemia (AMKL) is a rare disease, occurring mostly in infants and young children. The chromosomal translocation t(1;22)(p13;q13), resulting in the RBM15-MKL1 fusion gene, is a recurrent and diagnostic translocation in infants with AMKL. The present case report describes a case of a newborn girl, without Down's syndrome, with congenital AMKL. At birth, the infant had hepatosplenomegaly and the peripheral blood count revealed anemia, thrombopenia and leukocytosis, with 28% blasts. Immunophenotyping demonstrated blasts positive for CD34, CD61 and CD42b. Karyotyping of these blasts (R-banding) showed a hitherto unreported chromosomal translocation, t(1;7;22)(p13;q21;q13), a 3-way variant of the t(1;22)(p13;q13) variant. Fluorescent in situ hybridization analysis confirmed the presence of the RBM15-MKL1 fusion gene.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
t(1;7;22)(p13;q21;q13)是t(1;22)(p13;q13)新生儿急性巨核细胞白血病的一种新的3向变异。
急性巨核母细胞白血病(AMKL)是一种罕见的疾病,多见于婴幼儿。染色体易位t(1;22)(p13;q13)导致RBM15-MKL1融合基因,是AMKL婴儿中一种复发性和诊断性易位。本病例报告描述了一例新生女婴,无唐氏综合征,先天性AMKL。出生时,婴儿肝脾肿大,外周血计数显示贫血、血小板减少和白细胞增多,有28%的细胞。免疫分型显示母细胞CD34、CD61和CD42b阳性。这些细胞的核型(r带)显示了迄今未报道的染色体易位,t(1;7;22)(p13;q21;q13), t(1;22)(p13;q13)变体的三向变体。荧光原位杂交分析证实存在RBM15-MKL1融合基因。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.80
自引率
0.00%
发文量
108
期刊最新文献
TTF-1 expression is associated with survival in patients with non-squamous non-small cell lung cancer treated with immune checkpoint inhibitor therapy. D-dimer as a more effective marker for detecting thrombosis in patients with ovarian clear cell carcinoma compared with high-grade serous carcinoma. A prognostic gene signature derived from aging-related genes predicts survival, immune landscape and therapy response in glioma. Role of posterosuperior pancreatic lymph nodes in gallbladder cancer: A study using the efficacy index. Tertiary lymphoid structure can be a potential therapeutic target for head and neck squamous cell carcinoma (Review).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1